期刊文献+

奥林巴斯AU5400全自动生化分析仪检测尿素氮临床可报告范围的建立与评价 被引量:9

Establishment and evaluation of the clinical reportable range of BUN detected by Olympus AU5400 automatic analyzer
暂未订购
导出
摘要 目的建立奥林巴斯AU5400全自动生化分析仪检测尿素氮的临床可报告范围。方法参考美国临床检验标准化协会(CLSI)EP6-A文件和相关文献,在奥林巴斯AU5400全自动生化分析仪上进行尿素氮功能灵敏度验证实验、分析测量范围验证实验、最大允许稀释度验证实验,并由此建立其临床可报告范围。结果 BUN的分析测量范围为0.84~47.01mmol/L,最大允许稀释度为1:50,其临床可报告范围为0.66~2350.5mmol/L。结论奥林巴斯AU5400对BUN检测结果可靠准确,线性范围宽,适合常规检测。 Objective To establish and evaluate the clinical reportable range of BUN detected by Olympus AU5400 automatic analyzer.Methods Referring to CLSI EP6-A guideline and pertinent literature,we performed the validate experiments of analytical measurement range and max dilution limit by Olympus AU5400 automatic analyzer.The clinical reportable range was established with above results combining functional sensitivity.Results The analytical measurement range of BUN was 0.60-47.01mmol/L.The max dilution limit was 1:50 and the clinical reportable range was 0.66-2350.5mmol/L.Conclusions Olympus AU5400 automatic analyzer has broad linearity range,and its results show better sensitive and accurate,which is suited for detecting BUN in routine.
出处 《实验与检验医学》 CAS 2011年第2期117-120,共4页 Experimental and Laboratory Medicine
基金 广东省佛山市医学类科技攻关项目 编号200708051
关键词 临床可报告范围 分析测量范围 功能灵敏度 最大稀释度 EP6-A Clinical reportable range Analytical measurement range Functional Sensitivity Max dilution limit EP6-A
  • 相关文献

参考文献10

二级参考文献15

  • 1张心菊,吴炯,郭玮,潘柏申.强生Vitros 950生化检测系统性能验证[J].检验医学,2006,21(6):564-569. 被引量:8
  • 2NCCLS. Preliminary Evaluation of quantitative clinical laboratory methods: Approved Guideline[S]. EP10-A2, 2002.
  • 3魏吴,丛玉隆.医学实验室质量管理与认可指南[M].第1版,北京:中国计量出版社.2004:27-80.
  • 4冯仁丰.临床检验管理技术基础[M].第1版,上海:上海科学文献出版社.2003:2-7.
  • 5National Committee of Clinical Laboratory Standard. Evaluation of the linearity of quantitative measurement procedures: a statistical approach. Approved guideline. NCCLS document EP6-A[S]. Wayne, Pennsylvania: NCCLS, 2003,23(16):1-100.
  • 6[1]Davenport JM,Schlain B.Testing claimed minimal detectable concentrations of in vitro medical diagnostic devices[J].Clin Chem,2000,46:1669-1680.
  • 7[2]Diamandis EP,Yu J,Melegos DN.Ultrasensitive Prostate-specific antigen assaya and their clinical application[J].Clin Chem,l996,42:853-857.
  • 8[3]Stamey TA.Lower lin\mits of detection,Biological detection limits,functional sensitivity,or residual cancer detection? Sensitivity report on Prostate-specific antigen assays mislead clinicians[J].Clin Chem,1996,42:849-852.
  • 9[4]Clinical Laboratory Improvement Amendments of 1988.
  • 10[5]Jofis RD,Mare LB,Ivan KS,et al.Characteristics of creatine release during acute myocardial infarction,unstable angina,and cardiac surgery.Clin Chem,1995,41:928-933.

共引文献98

同被引文献59

  • 1施金俏,俞北伟.应用EP7文件对性激素测定的干扰评价[J].检验医学,2006,21(3):289-291. 被引量:8
  • 2毕波,吕元.定量检测方法学性能验证的系统设计[J].中华检验医学杂志,2007,30(2):143-145. 被引量:153
  • 3田峰.贝克曼CX4生化仪上使用开放试剂测试肝功能项目的探讨[J].现代检验医学杂志,2007,22(2):84-85. 被引量:1
  • 4杨有业,张秀明.临床检验方法学评价[M].北京:人民卫生出版社,2008:118-127.
  • 5魏吴 丛玉隆.医学实验室质量管理与认可指南[M].北京:中国计量出版社,2004.27-80.
  • 6扬振华,王治国.临床实验室质量管理[M].北京:人民卫生出版社,2003:157-159.
  • 7U.S. Department of Health and Human Services, Centers for Medicare& Medicaid Services. Clinical laboratory improvement a- mendments of 1988: final rule[J]. Fed Register, 1992, 57(40): 7002-7186.
  • 8National Committee of Clinical Laboratory Standard. Evaluation of the linearity of quantitative measurement procedures: a statistical approach. Approved guideline. NCCLS document EP6-A[S]. Wayne, Pennsylvania: NCCLS, 2003, 23(16): 1-100.
  • 9卢斯猛,李洪亮,赵卫兵,王守勇,薛永,张亚东.成人癫痫患者免疫球蛋白和补体测定[J].现代医药卫生,2007,23(22):3353-3354. 被引量:1
  • 10Jhang JS, Chang CC, Fink D J, et al. Evaluation of linearity in the clinical Laboratory[J]. Arch Pathol Lab Med, 2004,128 ( 1 ) :44-48.

引证文献9

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部